Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.150
+0.040 (1.90%)
At close: Aug 1, 2025, 4:00 PM
2.150
0.00 (0.00%)
After-hours: Aug 1, 2025, 4:00 PM EDT
Despegar.com Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Despegar.com stock has a target of 11, which predicts a 411.63% increase from the current stock price of 2.15.
Price Target: $11.00 (+411.63%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 24, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Despegar.com is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 → $11 | Strong Buy | Reiterates | $12 → $11 | +411.63% | Apr 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +434.88% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +434.88% | Feb 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +434.88% | Jan 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +434.88% | Dec 9, 2024 |
Financial Forecast
Revenue This Year
76.16M
from 20.12M
Increased by 278.51%
Revenue Next Year
129.59M
from 76.16M
Increased by 70.16%
EPS This Year
0.09
from -0.61
EPS Next Year
0.45
from 0.09
Increased by 402.84%
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 193.2M | 302.4M | 125.5M | ||
| Avg | 76.2M | 129.6M | 72.2M | ||
| Low | 12.7M | 6.6M | 23.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 860.2% | 297.1% | -3.2% | ||
| Avg | 278.5% | 70.2% | -44.3% | ||
| Low | -37.0% | -91.3% | -82.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.41 | 1.88 | -0.63 |
| Avg | 0.09 | 0.45 | -0.61 |
| Low | -0.74 | -0.74 | -0.59 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 2,014.6% | - |
| Avg | - | 402.8% | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.